Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALSGlobeNewsWire • 11/20/24
LLY Oral Cholesterol Drug Lowers Lipoprotein Levels in Phase II StudyZacks Investment Research • 11/19/24
Lilly's muvalaplin lowered lipoprotein(a) levels in adults with high risk for cardiovascular events by up to 85% at highest tested dosePRNewsWire • 11/18/24
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should KnowZacks Investment Research • 11/18/24
Incyclix Bio Announces Clinical Trial Collaboration and Supply Agreement with Lilly to Evaluate INX-315 in Combination with Verzenio® (abemaciclib) and Fulvestrant in HR+/HER2- Breast CancerGlobeNewsWire • 11/18/24
If You Bought 1 Share of Eli Lilly in 1984, Here's How Many Shares You Would Own NowThe Motley Fool • 11/17/24
Lilly's tirzepatide reduced the risk of worsening heart failure events by 38% in adults with heart failure with preserved ejection fraction (HFpEF) and obesityPRNewsWire • 11/16/24
Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretaryFast Company • 11/15/24
99% Of Mounjaro/Zepbound Patients Remained Diabetes-Free Even At 3 Years, Eli Lilly's Detailed Phase 3 Data ShowsBenzinga • 11/14/24